FDA recognizes Cognoa ' s child development app as autism diagnostic
Palo Alto, California-based Cognoa ’s machine learning app for pediatric behavioral health has received categorization from the FDA as a Class 2 diagnostic medical device for autism, according to an announcement from the company.
Source: mobihealthnews - Category: Information Technology Source Type: news
More News: Autism | Child Development | Children | Information Technology | Learning | Medical Devices | Pediatrics | Universities & Medical Training